Daiichi Sankyo Takes Aim at Top Spot in Japan Ethical Drug Market: Next President

February 27, 2017
Daiichi Sankyo’s Incoming President Sunao Manabe Sunao Manabe, incoming president of Daiichi Sankyo, has expressed his eagerness to capture the top spot in Japan ethical drug sales in the near future by bolstering the company’s anticoagulant Lixiana (edoxaban) and other...read more